ClinicalTrials.Veeva

Menu

Korean Heart Failure Registry III (KorHF-III)

Seoul National University logo

Seoul National University

Status

Enrolling

Conditions

Acute Heart Failure

Study type

Observational

Funder types

Other

Identifiers

NCT04329234
KorHF-III

Details and patient eligibility

About

KorHF III is a multi-center, nationwide, prospective registry of the Korean Society of Heart Failure, which enrolls patients with acute heart failure in Korea.

The aim of this registry is to analyze the etiology, treatment, treatment, and prognosis to develop strategies for managing acute heart failure.

Enrollment

10,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

All consecutive hospitalized adult heart failure patients who fulfill one of 1-3 and 4

Inclusion Criteria:

  1. Symptoms of heart failure
  2. Signs of heart failure
  3. Lung congestion in Chest-x-ray
  4. Objective finding of structural and/or functional disorder of the heart or elevated natriuretic peptide levels

Exclusion Criteria:

  1. Patients younger than 18 years old
  2. Patients who do no consent

Trial design

10,000 participants in 1 patient group

acute heart failure
Description:
Patients with acute heart failure

Trial contacts and locations

1

Loading...

Central trial contact

Jin Joo Park, MD, PhD; Dong-Ju Choi, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems